Bleakley Financial Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$533K Sell
11,272
-973
-8% -$50K 0.01% 780
2026
Q1
$726K Sell
12,245
-372
-3% -$24.1K 0.01% 586
2025
Q4
$778K Buy
12,617
+1,705
+16% +$104K 0.01% 520
2025
Q3
$681K Buy
+10,912
New +$760K 0.02% 472

Other funds holding PBH

Bleakley Financial Group's PBH Position: Q2 2026 in Review

Bleakley Financial Group reduced its Prestige Consumer Healthcare (PBH) stake by 7.9% in Q2 2026, selling an estimated $50K and leaving 11,272 shares worth $533K. The position accounts for 0.01% of the portfolio, ranked #780.

Bleakley Financial Group first reported a position in PBH in Q3 2025 and has held it in 4 quarters since. The position peaked at $778K in Q4 2025. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Bleakley Financial Group held 11,272 shares of Prestige Consumer Healthcare worth $533K as of Q2 2026.
  • Bleakley Financial Group sold 973 Prestige Consumer Healthcare shares in Q2 2026, an estimated $50K.
  • Prestige Consumer Healthcare made up 0.01% of Bleakley Financial Group's portfolio in Q2 2026, its #780 holding.
  • Bleakley Financial Group first reported a position in Prestige Consumer Healthcare in Q3 2025 and has held it in 4 quarters since.
  • Bleakley Financial Group's Prestige Consumer Healthcare position peaked at $778K in Q4 2025.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.